Penckofer, Sue et al
Reseas verificadas Calificacin promedio: 4.7 de 5, basada en 3 reseas de investigadores verificados
Semaglutide Is the Better-Evidenced Agent Several randomized trials conducted between 2021 and 2025 showed semaglutide 1.02.4mg weekly produces roughly 1015% weight loss in PCOS patients over 612 months, with parallel improvements in menstrual cycle frequency, testosterone, sex hormone-binding globulin (SHBG), and HOMA-IR (a marker of insulin resistance)
These sources are unverified and subject to manipulation in both directions, so they require critical reading
There is a slightly higher risk of a low blood sugar episode if you combine oral semaglutide with injectable insulin or drugs that trigger insulin secretion (sulfonylureas)
Zhao S, Ling YH, Snell V, Zhang X, Reed JC, Perez-Soler R, Andreeff M